Infarto agudo de miocardio. SCACEST

Thygesen, 2018, J Am Coll Cardiol., 72, 2231, 10.1016/j.jacc.2018.08.1038 Ibáñez, 2018, Eur Heart J., 39, 119, 10.1093/eurheartj/ehx393 Scirica, 2019, Infarto de miocardio con elevación del segmento ST: fisiopatología y evolución clínica, 1095 Gharacholou, 2010, Implications and reasons for the lack of use of reperfusion therapy in patients with ST-segment elevation myocardial infarction: findings from the CRUSADE initiative, Am Heart J., 159, 757, 10.1016/j.ahj.2010.02.009 Monsieurs, 2015, European Resuscitation Council Guidelines for Resuscitation 2015: Section 1. Executive summary, Resuscitation, 95, 1, 10.1016/j.resuscitation.2015.07.038 Hypothermia after Cardiac Arrest Study Group, 2002, Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest, N Engl J Med., 346, 549, 10.1056/NEJMoa012689 O’Gara, 2013, 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol., 61, e78, 10.1016/j.jacc.2012.11.019 Sgarbossa, 1996, Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators, N Engl J Med., 334, 481, 10.1056/NEJM199602223340801 Sgarbossa, 1996, Early electrocardiographic diagnosis of acute myocardial infarction in the presence of ventricular paced rhythm. GUSTO-I investigators, Am J Cardiol., 77, 423, 10.1016/S0002-9149(97)89377-0 Yan, 2007, GRACE Investigators. Relationship of ST elevation in lead aVR with angiographic findings and outcome in non-ST elevation acute coronary syndromes, Am Heart J, 154, 71, 10.1016/j.ahj.2007.03.037 Wagner, 2008 Townsend, 2016, Cardiovascular disease in Europe: epidemiological update 2016, Eur Heart J., 37, 3232, 10.1093/eurheartj/ehw334 Cabello, 2013, Oxygen therapy for acute myocardial infarction, Cochrane Database Syst Rev, 8, CD007160 Fordyce, 2017, STEMI Systems Accelerator Project. Association of rapid care process implementation on reperfusion times across multiple ST-segment-elevation myocardial infarction networks, Circ Cardiovasc Interv., 10, e004061, 10.1161/CIRCINTERVENTIONS.116.004061 Keeley, 2003, Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials, Lancet, 361, 13, 10.1016/S0140-6736(03)12113-7 Kastrati, 2007, Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction, Eur Heart J., 28, 2706, 10.1093/eurheartj/ehm402 De Luca, 2017, Drug-Eluting Stent in Primary Angioplasty (DESERT 3) cooperation. Everolimus eluting stent vs first generation drug-eluting stent in primary angioplasty: A pooled patient-level meta-analysis of randomized trials, Int J Cardiol., 244, 121, 10.1016/j.ijcard.2017.06.022 Elgendy, 2017, Complete or culprit-only revascularization for patients with multivessel coronary artery disease undergoing percutaneous coronary intervention: a pairwise and network meta-analysis of randomized trials, JACC Cardiovasc Interv., 10, 315, 10.1016/j.jcin.2016.11.047 Schüpke, 2019, ISAR-REACT 5 Trial Investigators. Ticagrelor or prasugrel in patients with acute coronary syndromes, N Engl J Med., 381, 1524, 10.1056/NEJMoa1908973 Yusuf, 2006, OASIS-6 Trial Group. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial, JAMA, 295, 1519, 10.1001/jama.295.13.joc60038 Morrison, 2000, Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis, JAMA, 283, 2686, 10.1001/jama.283.20.2686 Van de Werf, 1999, Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Investigators. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial, Lancet, 354, 716, 10.1016/S0140-6736(99)07403-6 Van de Werf, 2001, ASSENT-2 Investigators, Assessment of the safety and efficacy of a new thrombolytic. Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA, Eur Heart J, 22, 2253, 10.1053/euhj.2001.2686 Anderson, 2016, Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis, J Am Coll Cardiol., 67, 1, 10.1016/j.jacc.2015.10.044 Mach, 2020, ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk, Eur Heart J., 41, 111, 10.1093/eurheartj/ehz455 Fox, 2014, Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score, BMJ Open., 4, e004425, 10.1136/bmjopen-2013-004425